Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval
Submitted by
admin
on December 3, 2014 - 8:13am
Source:
Yahoo
News Tags:
Genzyme
MS
multiple sclerosis
Lemtrada
Headline:
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval
Do Not Allow Advertisers to Use My Personal information